Supervised atenolol therapy in the management of hemodialysis hypertension
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 55 (4) , 1528-1535
- https://doi.org/10.1046/j.1523-1755.1999.00359.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hypertension and Cardiac Death in Dialysis Patients-Should Target Blood Pressure Be Lowered?Seminars in Dialysis, 2007
- Role of volume overload in dialysis-refractory hypertensionAmerican Journal of Kidney Diseases, 1996
- Hypertension in the hemodialysis population: A survey of 649 patientsAmerican Journal of Kidney Diseases, 1995
- Control of Blood Pressure in Long Slow HemodialysisBlood Purification, 1994
- Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agentsThe American Journal of Medicine, 1993
- Survival as an index of adequacy of dialysisKidney International, 1992
- Blood Pressure Elevation during the Night in Chronic Renal Failure, Hemodialysis and after Renal TransplantationNephron, 1991
- Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.Circulation, 1990
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.British Journal of Clinical Pharmacology, 1980